These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22454087)

  • 1. Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist.
    Li CS; Zhang L; Haske T; Dounay A; Gray D; Barta N; Brodfuehrer J; Lepsy C; Campbell B
    AAPS J; 2012 Jun; 14(2):365-76. PubMed ID: 22454087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.
    Pettersson M; Campbell BM; Dounay AB; Gray DL; Xie L; O'Donnell CJ; Stratman NC; Zoski K; Drummond E; Bora G; Probert A; Whisman T
    Bioorg Med Chem Lett; 2011 Jan; 21(2):865-8. PubMed ID: 21185183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.
    Liu YP; Wilkinson LS; Robbins TW
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):175-85. PubMed ID: 14726995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.
    Swanson CJ; Perry KW; Koch-Krueger S; Katner J; Svensson KA; Bymaster FP
    Neuropharmacology; 2006 May; 50(6):755-60. PubMed ID: 16427661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
    Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
    Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.
    Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
    Br J Pharmacol; 2010 Aug; 160(8):1929-40. PubMed ID: 20649591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice.
    Tsuchida R; Kubo M; Kuroda M; Shibasaki Y; Shintani N; Abe M; Köves K; Hashimoto H; Baba A
    J Pharmacol Sci; 2009 Mar; 109(3):396-402. PubMed ID: 19270432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.
    Ago Y; Umehara M; Higashino K; Hasebe S; Fujita K; Takuma K; Matsuda T
    Neurochem Res; 2014 May; 39(5):825-32. PubMed ID: 24634253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
    Huang M; Li Z; Dai J; Shahid M; Wong EH; Meltzer HY
    Neuropsychopharmacology; 2008 Nov; 33(12):2934-45. PubMed ID: 18418367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats.
    Alfinito PD; Huselton C; Chen X; Deecher DC
    Brain Res; 2006 Jul; 1098(1):71-8. PubMed ID: 16764833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
    Bradshaw SE; Agster KL; Waterhouse BD; McGaughy JA
    Brain Res; 2016 Jun; 1641(Pt B):245-57. PubMed ID: 26774596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
    Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity.
    Astier B; Lambás Señas L; Soulière F; Schmitt P; Urbain N; Rentero N; Bert L; Denoroy L; Renaud B; Lesourd M; Muñoz C; Chouvet G
    Eur J Pharmacol; 2003 Jan; 459(1):17-26. PubMed ID: 12505530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.
    Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
    Psychopharmacology (Berl); 2012 May; 221(2):261-72. PubMed ID: 22147258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of maternal ethanol consumption and buspirone treatment on dopamine and norepinephrine reuptake sites and D1 receptors in offspring.
    Gillespie RA; Eriksen J; Hao HL; Druse MJ
    Alcohol Clin Exp Res; 1997 May; 21(3):452-9. PubMed ID: 9161605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
    Gray DL; Xu W; Campbell BM; Dounay AB; Barta N; Boroski S; Denny L; Evans L; Stratman N; Probert A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6604-7. PubMed ID: 19854053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.